Torsten Pietsch
Torsten Pietsch
Professor and Chairman, Institute of Neuropathology, University of Bonn
Verified email at
Cited by
Cited by
Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors
B Lustig, B Jerchow, M Sachs, S Weiler, T Pietsch, U Karsten, ...
Molecular and cellular biology 22 (4), 1184-1193, 2002
Long-term survival with glioblastoma multiforme
D Krex, B Klink, C Hartmann, A von Deimling, T Pietsch, M Simon, ...
Brain 130 (10), 2596-2606, 2007
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
W Wick, C Hartmann, C Engel, M Stoffels, J Felsberg, F Stockhammer, ...
Journal of clinical oncology 27 (35), 5874, 2009
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ...
Acta neuropathologica 123 (4), 473-484, 2012
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski, U Bode, F Deinlein, H Ottensmeier, M Warmuth-Metz, ...
New England Journal of Medicine 352 (10), 978-986, 2005
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
M Kool, J Koster, J Bunt, NE Hasselt, A Lakeman, P Van Sluis, D Troost, ...
PloS one 3 (8), e3088, 2008
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the …
C Hartmann, B Hentschel, W Wick, D Capper, J Felsberg, M Simon, ...
Acta neuropathologica 120 (6), 707-718, 2010
Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network
M Weller, J Felsberg, C Hartmann, H Berger, JP Steinbach, J Schramm, ...
Journal of Clinical Oncology 27 (34), 5743-5750, 2009
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre …
R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ...
The lancet oncology 15 (10), 1100-1108, 2014
DNA methylation-based classification of central nervous system tumours
D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Nature 555 (7697), 469-474, 2018
Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups
KW Pajtler, H Witt, M Sill, DTW Jones, V Hovestadt, F Kratochwil, K Wani, ...
Cancer cell 27 (5), 728-743, 2015
NeuN: a useful neuronal marker for diagnostic histopathology.
HK Wolf, R Buslei, R Schmidt-Kastner, PK Schmidt-Kastner, T Pietsch, ...
Journal of Histochemistry & Cytochemistry 44 (10), 1167-1171, 1996
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
E Thiel, A Korfel, P Martus, L Kanz, F Griesinger, M Rauch, A Röth, ...
The lancet oncology 11 (11), 1036-1047, 2010
I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading
DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ...
Brain pathology 24 (5), 429-435, 2014
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
S Pfister, WG Janzarik, M Remke, A Ernst, W Werft, N Becker, G Toedt, ...
The Journal of clinical investigation 118 (5), 1739-1749, 2008
Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched
T Pietsch, A Waha, A Koch, J Kraus, S Albrecht, J Tonn, N Sörensen, ...
Cancer research 57 (11), 2085-2088, 1997
Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene
A Koch, D Denkhaus, S Albrecht, I Leuschner, D von Schweinitz, ...
Cancer research 59 (2), 269-273, 1999
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed …
R Stupp, ME Hegi, B Neyns, R Goldbrunner, U Schlegel, PM Clement, ...
Journal of clinical oncology 28 (16), 2712-2718, 2010
New brain tumor entities emerge from molecular classification of CNS-PNETs
D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ...
Cell 164 (5), 1060-1072, 2016
Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate
E Wardelmann, S Merkelbach-Bruse, K Pauls, N Thomas, HU Schildhaus, ...
Clinical Cancer Research 12 (6), 1743-1749, 2006
The system can't perform the operation now. Try again later.
Articles 1–20